FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to bioencapsulation, particularly to a method for cephalosporin bioencapsulation, wherein a microcapsule coating is human leucocyte α- or β-interferon. According to the method, power cephalosporin 0.060 g or 0.075 g respectively and E472c preparation 0.05 g as a surfactant are added to 1% aqueous human leucocyte α- or β-interferon 2 g or 2.5 g; the prepared mixture is stirred until the ingredients of the reaction mixture are dissolved completely. Forming a transparent solution is followed by slow drop-by-drop addition of methyl carbinol 1 ml as a first precipitating agent and isopropanol 5 ml as a second precipitating agent; then acetone is added, and the mixture is dried. The method is implemented at 25°C with no special equipment applied.
EFFECT: simplifying and accelerating the process of microcapsules in interferon and higher weight yield.
4 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF BIOENCAPSULATION | 2013 |
|
RU2538668C1 |
METHOD FOR BIOENCAPSULATION | 2013 |
|
RU2538807C1 |
METHOD FOR BIOENCAPSULATION | 2013 |
|
RU2538646C1 |
METHOD OF BIOENCAPSULATION | 2013 |
|
RU2558077C2 |
METHOD OF BIOENCAPSULATION | 2013 |
|
RU2555466C2 |
METHOD OF PRODUCING MICROCAPSULES OF CEPHALOSPORIN ANTIBIOTICS IN INTERFERONS | 2013 |
|
RU2580614C2 |
METHOD FOR CEPHALOSPORIN BIOENCAPSULATION | 2013 |
|
RU2538806C2 |
METHOD OF BIOENCAPSULATION OF CEPHALOSPORIN GROUP MEDICATIONS | 2013 |
|
RU2554277C2 |
METHOD OF BIOENCAPSULATION OF CEPHALOSPORIN GROUP MEDICATIONS | 2013 |
|
RU2545723C2 |
METHOD FOR CEPHALOSPORIN BIOENCAPSULATION | 2013 |
|
RU2539898C2 |
Authors
Dates
2015-01-10—Published
2013-05-22—Filed